Cargando…
Real-World Evaluation of a Population Germline Genetic Screening Initiative for Family Medicine Patients
Hereditary factors contribute to disease development and drug pharmacokinetics. The risk of hereditary disease development can be attenuated or eliminated by early screening or risk reducing interventions. The purpose of this study was to assess the clinical utility of germline medical exome sequenc...
Autores principales: | Hutchcraft, Megan Leigh, Zhang, Shulin, Lin, Nan, Gottschalk, Ginny Lee, Keck, James W., Belcher, Elizabeth A., Sears, Catherine, Wang, Chi, Liu, Kun, Dietz, Lauren E., Pickarski, Justine C., Wei, Sainan, Cardarelli, Roberto, DiPaola, Robert S., Kolesar, Jill M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410316/ https://www.ncbi.nlm.nih.gov/pubmed/36013246 http://dx.doi.org/10.3390/jpm12081297 |
Ejemplares similares
-
Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes
por: Hutchcraft, Megan L., et al.
Publicado: (2021) -
MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer
por: Hutchcraft, Megan L., et al.
Publicado: (2021) -
Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice
por: Rives, Taylor A., et al.
Publicado: (2023) -
Prevalence of SARS-CoV-2 IgG antibodies in health care workers at a tertiary care academic medical center – An assessment of occupational infection risk
por: Forster, Derek, et al.
Publicado: (2021) -
Does the world need germline editing for β-thalassemia?
por: Kulozik, Andreas E.
Publicado: (2022)